D Mata-Mbemba1, M Zapotocky2, S Laughlin1, M D Taylor3, V Ramaswamy2, C Raybaud4. 1. From the Department of Diagnostic Imaging (D.M.-M., S.L., C.R.). 2. Division of Neuro-oncology (M.Z., V.R.). 3. Department of Neurosurgery (M.D.T.), Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. 4. From the Department of Diagnostic Imaging (D.M.-M., S.L., C.R.) charles.raybaud@sickkids.ca.
Abstract
BACKGROUND AND PURPOSE: Molecular grouping of medulloblastoma correlates with prognosis and supports the therapeutic strategy. We provide our experience with the imaging features of primary and metastatic disease in relation to the molecular groups. MATERIALS AND METHODS: One hundred nineteen consecutive patients (mean age, 7.3 ± 3.8 years at diagnosis; male, 79 [66.4%]) with a confirmed diagnosis of medulloblastoma and interpretable pretreatment MRIs were retrieved from our data base from January 2000 to December 2016. Each patient was assigned to wingless, sonic hedgehog, group 3, or group 4 molecular groups. Then, we determined the imaging features of both primary and metastatic/recurrent disease predictive of molecular groups. RESULTS: In addition to recently reported predictors based on primary tumor, including cerebellar peripheral location for sonic hedgehog (adjusted odds ratio = 9, P < .0001), minimal enhancement of primary group 4 tumor (adjusted odds ratio = 5.2, P < .0001), and cerebellopontine angle location for wingless (adjusted odds ratio = 1.4, P = .03), ependymal metastasis with diffusion restriction and minimal postcontrast enhancement ("mismatching pattern") (adjusted odds ratio = 2.8, P = .001) for group 4 and spinal metastasis for group 3 (adjusted odds ratio = 1.9, P = .01) also emerged as independent predictors of medulloblastoma molecular groups. Specifically, the presence of a metastasis in the third ventricular infundibular recess showing a mismatching pattern was significantly associated with group 4 (P = .02). CONCLUSIONS: In addition to imaging features of primary tumors, some imaging patterns of metastatic dissemination in medulloblastoma seem characteristic, perhaps even specific to certain groups. This finding could further help in differentiating molecular groups, specifically groups 3 and 4, when the characteristics of the primary tumor overlap.
BACKGROUND AND PURPOSE: Molecular grouping of medulloblastoma correlates with prognosis and supports the therapeutic strategy. We provide our experience with the imaging features of primary and metastatic disease in relation to the molecular groups. MATERIALS AND METHODS: One hundred nineteen consecutive patients (mean age, 7.3 ± 3.8 years at diagnosis; male, 79 [66.4%]) with a confirmed diagnosis of medulloblastoma and interpretable pretreatment MRIs were retrieved from our data base from January 2000 to December 2016. Each patient was assigned to wingless, sonic hedgehog, group 3, or group 4 molecular groups. Then, we determined the imaging features of both primary and metastatic/recurrent disease predictive of molecular groups. RESULTS: In addition to recently reported predictors based on primary tumor, including cerebellar peripheral location for sonic hedgehog (adjusted odds ratio = 9, P < .0001), minimal enhancement of primary group 4 tumor (adjusted odds ratio = 5.2, P < .0001), and cerebellopontine angle location for wingless (adjusted odds ratio = 1.4, P = .03), ependymal metastasis with diffusion restriction and minimal postcontrast enhancement ("mismatching pattern") (adjusted odds ratio = 2.8, P = .001) for group 4 and spinal metastasis for group 3 (adjusted odds ratio = 1.9, P = .01) also emerged as independent predictors of medulloblastoma molecular groups. Specifically, the presence of a metastasis in the third ventricular infundibular recess showing a mismatching pattern was significantly associated with group 4 (P = .02). CONCLUSIONS: In addition to imaging features of primary tumors, some imaging patterns of metastatic dissemination in medulloblastoma seem characteristic, perhaps even specific to certain groups. This finding could further help in differentiating molecular groups, specifically groups 3 and 4, when the characteristics of the primary tumor overlap.
Authors: A Stock; M Mynarek; T Pietsch; S M Pfister; S C Clifford; T Goschzik; D Sturm; E C Schwalbe; D Hicks; S Rutkowski; B Bison; M Pham; M Warmuth-Metz Journal: AJNR Am J Neuroradiol Date: 2019-10-24 Impact factor: 3.825
Authors: L Cardoen; A Tauziède-Espariat; V Dangouloff-Ros; S Moalla; N Nicolas; C-J Roux; Y Bouchoucha; F Bourdeaut; K Beccaria; S Bolle; G Pierron; C Dufour; F Doz; N Boddaert; H J Brisse Journal: AJNR Am J Neuroradiol Date: 2021-12-09 Impact factor: 3.825
Authors: A Trasolini; C Erker; S Cheng; C Crowell; K McFadden; R Moineddin; M A Sargent; D Mata-Mbemba Journal: AJNR Am J Neuroradiol Date: 2022-07-21 Impact factor: 4.966
Authors: John T Lucas; Christopher L Tinkle; Jie Huang; Arzu Onar-Thomas; Sudharsan Srinivasan; Parker Tumlin; Jared B Becksfort; Paul Klimo; Frederick A Boop; Giles W Robinson; Brent A Orr; Julie H Harreld; Matthew J Krasin; Paul A Northcott; David W Ellison; Amar Gajjar; Thomas E Merchant Journal: Neuro Oncol Date: 2022-07-01 Impact factor: 13.029
Authors: Michael Zhang; Samuel W Wong; Jason N Wright; Matthias W Wagner; Sebastian Toescu; Michelle Han; Lydia T Tam; Quan Zhou; Saman S Ahmadian; Katie Shpanskaya; Seth Lummus; Hollie Lai; Azam Eghbal; Alireza Radmanesh; Jordan Nemelka; Stephen Harward; Michael Malinzak; Suzanne Laughlin; Sébastien Perreault; Kristina R M Braun; Robert M Lober; Yoon Jae Cho; Birgit Ertl-Wagner; Chang Y Ho; Kshitij Mankad; Hannes Vogel; Samuel H Cheshier; Thomas S Jacques; Kristian Aquilina; Paul G Fisher; Michael Taylor; Tina Poussaint; Nicholas A Vitanza; Gerald A Grant; Stefan Pfister; Eric Thompson; Alok Jaju; Vijay Ramaswamy; Kristen W Yeom Journal: Radiology Date: 2022-04-19 Impact factor: 29.146
Authors: Rashad Jabarkheel; Nisreen Amayiri; Derek Yecies; Yuhao Huang; Sebastian Toescu; Liana Nobre; Donald J Mabbott; Sniya V Sudhakar; Prateek Malik; Suzanne Laughlin; Maisa Swaidan; Maysa Al Hussaini; Awni Musharbash; Geeta Chacko; Leni G Mathew; Paul G Fisher; Darren Hargrave; Ute Bartels; Uri Tabori; Stefan M Pfister; Kristian Aquilina; Michael D Taylor; Gerald A Grant; Eric Bouffet; Kshitij Mankad; Kristen W Yeom; Vijay Ramaswamy Journal: Neuro Oncol Date: 2020-02-20 Impact factor: 12.300